Gil J. van Lunsen, Director at ARRAY BIOPHARMA INC (ARRY), sold 21,500 shares at $15.19 ($327K) on 2018-04-18, disclosed to the SEC on 2018-04-18.
Open-market sale of $327k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2018-07-19 | $356K | — | Filing → |
| ARRY | SELL | 2018-06-21 | $820K | — | Filing → |
| ARRY | SELL | 2018-05-17 | $330K | — | Filing → |